Stansberry Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$224K Buy
+881
New +$205K 0.02% 141
2023
Q3
– Sell
-13,462
Closed -$2.23M – 110
2023
Q2
$2.23M Sell
13,462
-445
-3% -$71.8K 0.41% 71
2023
Q1
$2.16M Sell
13,907
-7,883
-36% -$1.27M 0.42% 63
2022
Q4
$3.85M Buy
21,790
+757
+4% +$131K 0.79% 40
2022
Q3
$3.44M Buy
21,033
+1,840
+10% +$311K 0.74% 45
2022
Q2
$3.41M Sell
19,193
-954
-5% -$170K 0.73% 48
2022
Q1
$3.57M Buy
20,147
+1,143
+6% +$194K 0.58% 46
2021
Q4
$3.25M Buy
19,004
+2,944
+18% +$482K 0.52% 45
2021
Q3
$2.59M Buy
+16,060
New +$2.74M 0.52% 45

Other funds holding JNJ

Stansberry Asset Management's JNJ Position: Q2 2026 in Review

Stansberry Asset Management opened a new position in Johnson & Johnson (JNJ) in Q2 2026: 881 shares worth $224K. The stake represents 0.02% of the portfolio and ranks #141 among its holdings. This is a return to the name: Stansberry Asset Management previously reported a position in JNJ as recently as Q2 2023.

Stansberry Asset Management first reported a position in JNJ in Q3 2021 and has held it in 9 quarters since. The position peaked at $3.85M in Q4 2022. 4,698 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Stansberry Asset Management held 881 shares of Johnson & Johnson worth $224K as of Q2 2026.
  • Johnson & Johnson was a new Stansberry Asset Management position in Q2 2026.
  • Johnson & Johnson made up 0.02% of Stansberry Asset Management's portfolio in Q2 2026, its #141 holding.
  • Stansberry Asset Management first reported a position in Johnson & Johnson in Q3 2021 and has held it in 9 quarters since.
  • Stansberry Asset Management's Johnson & Johnson position peaked at $3.85M in Q4 2022.
  • 4,698 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Stansberry Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.